Circulating levels of PAI-1 are increased in patients with obesity and metabolic dysfunction syndrome [171], and are independent risk factors for stroke, cardiovascular disease, and obesity-related cancers [[171], [172], [173]]. Here, SERPINE1 is linked to obesity disorder.